Clal Biotechnology Industries
Venture capitalTel Aviv · Seed–Late Stage · 9 people tracked
Investment thesis
CBI concentrates on the life sciences sector, backing companies that develop proprietary solutions addressing unmet medical needs with significant market potential. It builds and oversees a global portfolio of innovative healthcare ventures, aiming to advance treatments worldwide. As a publicly listed investment firm, CBI identifies and nurtures groundbreaking science-driven businesses from an early stage through their development.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website & curated & public directories_edited.jpg)
What they invest in
from 9 of 9 portfolio companiesHealthtech ×7Biotech ×6Medical Devices ×3AI & Machine Learning ×2Digital Health ×2Hardware ×2
HQs:United States×1
Investments · 9 tracked
founders shown can be your intro pathMediWound is a biotechnology company developing enzymatic treatments that selectively remove eschar tissue while preserving healthy tissue for burns and chronic wounds.
BiotechHealthtechMedical DevicesYavne
Boaz Gur-Lavie(Chief Financial Officer)Sharon Malka(Director)Ety Klinger(Executive Officer, Director)inTzvi Palash(Executive Officer)Assaf Segal(Director)Sharon Kochan(Director)
PartnerAvi Fischer· solo GP
Co-investorsDeep InsightGandyr InvestmentsIsrael Biotech FundNew Era Capital Partners
Biokine Therapeutics is a private biopharmaceutical company developing cancer therapeutics targeting tumor migration, survival, and immune-response pathways; its lead product BKT140/BL8040 is a CXCR4 receptor inhibitor used for stem cell mobilization and cancer immunotherapy.
BiotechHealthtech
PartnerAvi Fischer· solo GP
Colospan develops CG-100, a CE-marked intraluminal bypass device made of soft silicone that is placed through the anus to protect the surgical site after colorectal surgery, serving as an alternative to a diverting stoma.
HardwareHealthtechMedical Devices
PartnerAvi Fischer· solo GP
Co-investorsTriventures
Elicio develops cancer immunotherapies including vaccines, immunomodulators, and adjuvants built on its lymph node-targeted AMP platform to activate and amplify cancer-fighting T cells.
BiotechHealthtech
PartnerAvi Fischer· solo GP
FDNA develops AI-powered image analysis and decision-support tools that help parents, school nurses, and pediatric and genetic specialists detect developmental delays, genetic disorders, and rare diseases earlier.
AI & Machine LearningDigital HealthHealthtech
PartnerAvi Fischer· solo GP
BiotechCambridge, US
Richard Gaynor, M.D.(Executive Officer)Robert Ang, M.D.(Executive Officer)Yasir Al-Wakeel(Executive Officer)Eric Lander(Director)Hugh Dowd(Executive Officer, Director)
BoardCary Pfeffer, M.D.(Director)
Co-investorsNextech InvestSofinnova VenturesThird Rock Ventures
Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification.
HardwareHealthtechMedical Devices
Erez Golan(Founder)in
PartnerAvi Fischer· solo GP
Co-investorsAccelmed PartnersIndaco Venture PartnersSofinnova Partners
Sight develops immune signatures by analyzing live immune cells using AI to generate clinical insights.
AI & Machine LearningBiotechDigital Health
Ben Leshem(Chief Technology Officer)Nitsan Maayan-Rabinowich(Chief Executive Officer)Asi Cohen-Dotan(Chief Product & Clinical Officer)
PartnerAvi Fischer· solo GP
Co-investorsEmery CapitalGEOC
BiotechHealthtech
PartnerAvi Fischer· solo GP
Co-investorsExSight VenturesLongitude CapitalTachyon VenturesThe Column Group
Exits · 1
IPOs and acquisitions across the tracked portfolioMediwoundNASDAQ: MDWD
Frequently asked questions
- How many investments has Clal Biotechnology Industries made?
- Clal Biotechnology Industries has 8 tracked investments.
- What stage does Clal Biotechnology Industries invest at?
- Clal Biotechnology Industries invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Clal Biotechnology Industries focus on?
- Clal Biotechnology Industries focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Clal Biotechnology Industries located?
- Clal Biotechnology Industries is headquartered in Tel Aviv, IL.
- Who does Clal Biotechnology Industries co-invest with?
- Clal Biotechnology Industries most often shares deals with Indaco Venture Partners, Longitude Capital, New Era Capital Partners, among 14 tracked co-investors.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.